MabVax Financial Statements From 2010 to 2024

MabVax Therapeutics financial statements provide useful quarterly and yearly information to potential MabVax Therapeutics Holdings investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on MabVax Therapeutics financial statements helps investors assess MabVax Therapeutics' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting MabVax Therapeutics' valuation are summarized below:
MabVax Therapeutics Holdings does not presently have any fundamental ratios for analysis.
Check MabVax Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among MabVax main balance sheet or income statement drivers, such as , as well as many exotic indicators such as . MabVax financial statements analysis is a perfect complement when working with MabVax Therapeutics Valuation or Volatility modules.
  
This module can also supplement various MabVax Therapeutics Technical models . Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real.

MabVax Return On Asset Analysis

MabVax Therapeutics' Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.

Return On Asset

 = 

Net Income

Total Assets

More About Return On Asset | All Equity Analysis

Current MabVax Therapeutics Return On Asset

    
  -61.26  
Most of MabVax Therapeutics' fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, MabVax Therapeutics Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
Competition

Based on the latest financial disclosure, MabVax Therapeutics Holdings has a Return On Asset of -61.26. This is much higher than that of the Healthcare sector and 159.58% higher than that of the Biotechnology industry. The return on asset for all United States stocks is notably higher than that of the company.

MabVax Therapeutics Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining MabVax Therapeutics's current stock value. Our valuation model uses many indicators to compare MabVax Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across MabVax Therapeutics competition to find correlations between indicators driving MabVax Therapeutics's intrinsic value. More Info.
MabVax Therapeutics Holdings is considered to be number one stock in profit margin category among related companies. It is considered to be number one stock in cash and equivalents category among related companies . . Comparative valuation analysis is a catch-all model that can be used if you cannot value MabVax Therapeutics by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for MabVax Therapeutics' Pink Sheet . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the MabVax Therapeutics' earnings, one of the primary drivers of an investment's value.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real.
You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..

Other Consideration for investing in MabVax Pink Sheet

If you are still planning to invest in MabVax Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the MabVax Therapeutics' history and understand the potential risks before investing.
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Fundamental Analysis
View fundamental data based on most recent published financial statements